Anti-RNase L In Vivo Antibody - Low Endotoxin

(No reviews yet) Write a Review

제품 코드를 사용하여 Assay Genie 메인 사이트를 통해 주문합니다.

주문
SKU:
IVMB0387
Product Type:
In Vivo Monoclonal Antibody
Clone:
2e9
Protein:
RNaseL
Isotype:
IgG1 k
Reactivity:
Human
Reactivity:
Hamster
Reactivity:
Primate
Synonyms:
Ribonuclease 4
Synonyms:
Ribonuclease L,RNase L
Synonyms:
PRCA1,RNS4
Research Area:
Cell Biology
Research Area:
Immunology
Research Area:
Neuroinflammation
Research Area:
Neuroscience
Endotoxin Level:
Low Endotoxin
Host Species:
Mouse
Applications:
ELISA
Applications:
IHC FFPE
Applications:
In Vivo
Applications:
WB
€0.00
Frequently bought together:

Description

Product Name:Anti-RNase L In Vivo Antibody - Low Endotoxin
Product Code:IVMB0387
Size:1 mg, 5 mg, 25 mg, 50 mg, 100 mg
Clone:2e9
Protein:RNaseL
Product Type:Monoclonal Antibody
Synonyms:2',5'-oligoisoadenylate synthetase-dependent; 2-5A-dependent ribonuclease; 2-5A-dependent RNase; interferon-induced 2-5A-dependent RNase; Ribonuclease 4; Ribonuclease L; ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent); ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent); RNase L; PRCA1; RNS4
Isotype:IgG1 k
Reactivity:Human, Hamster, Primate
Applications:ELISA, IHC FFPE, In Vivo, WB
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Purity:≥95% monomer by analytical SEC ⋅ >95% by SDS Page
Product Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:ELISA, IHC FFPE, In Vivo, WB
Reactivity:Human/Hamster/Primate
Host Species:Mouse
Specificity:Clone 2E9 recognizes an epitope on human/hamster/primate RNaseL.
Antigen Distribution:RNase L is highly expressed in the spleen and thymus, followed by prostate, testis, uterus, small intestine, colon, and peripheral blood leukocytes.
Immunogen:Purified, full-length, recombinant, human RNaseL produced in insect cells.
Concentration:≥ 5.0 mg/ml
Endotoxin Level:< 1.0 EU/mg as determined by the LAL method
Formulation:This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:≥95% monomer by analytical SEC ⋅ >95% by SDS Page
Preparation:Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

RNase L antibody, clone 2E9, recognizes the interferon (IFN)-inducible 2-5A-dependent ribonuclease L (RNase L), an endoribonuclease involved in antiviral signaling. It is widely expressed as a latent monomer in most mammalian tissues1. 2’,5’-oligoadenylate synthetase (OAS) is expressed following viral infection and exposure to IFN2. OAS proteins are activated by dsRNA, resulting in the production of 2’,5’-linked oligoadenylates (2-5A), which bind to latent RNase L, inducing dimerization and activation2. RNase L inhibits viral replication by cleaving viral and ribosomal RNA3,4 and inducing apoptosis in virus-infected cells5,6. RNase L is suggested to have antitumor effects, possibly through its pro-apoptotic activity7, and mutations in the RNASEL gene are associated with prostate cancer risk and progression8,9.

Protein:RNaseL
Research Area:Cell Biology, Immunology, Neuroinflammation, Neuroscience
Shipping:2-8°C
PubMed:RNaseL
NCBI Gene Bank ID:6041
UniProt:Q05823
View AllClose

Related Products